Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors

Chen,Hui-Song; Xing,Su-Rong; Xu,Wei-Guo; Yang,Fan; Qi,Xiao‑Long; Wang,Le-Min; Yang,Chang-Qing

doi:10.3892/etm.2013.918

Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors

Authors:
- Hui-Song Chen
- Su-Rong Xing
- Wei-Guo Xu
- Fan Yang
- Xiao‑Long Qi
- Le-Min Wang
- Chang-Qing Yang
View Affiliations

Affiliations: Division of Gastroenterology and Digestive Diseases Institute, Tongji Hospital of Tongji University School of Medicine, Shanghai 200065, P.R. China
Published online on: January 22, 2013 https://doi.org/10.3892/etm.2013.918
Pages: 819-824

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The incidence and clinical features of portopulmonary hypertension (POPH) have not been adequately described and it is currently unknown whether an association exists between the severity of POPH and liver function. Additionally, POPH risk factors are yet to be identified. The aim of this study was to determine the prevalence, describe the clinical features and investigate the potential risk factors of POPH. We conducted a study of 100 cirrhotic patients hospitalized between March 2011 and May 2012 at Tongji Hospital in Shanghai. The clinical characteristics of patients with and without POPH were analyzed. Clinical variables with a possible association with POPH were measured and pulmonary artery systolic pressure (PASP) was determined by cardiac Doppler echocardiography. Of the 100 patients enrolled in this study, 10 were diagnosed with POPH. Seven of the cases were mild, two were moderate and only one was severe; eight were attributed to viral infections. POPH was not detected in patients with schistosomal or alcoholic cirrhosis. Hemoglobin (Hb) levels were lower in patients with POPH compared to those without POPH (P<0.01) and the severity of POPH was not significantly correlated with Child-Pugh grade (R=-0.06, P=0.09). Hb levels, incidence of hepatitis C virus (HCV) infection and portal vein thrombosis differed between the two groups (P<0.05). Hb levels were identified as an independent risk factor associated with POPH and portal vein thrombosis may play an important role during the development of POPH. However, the severity of POPH was not associated with liver function.

View Figures

View References

1.	Hadengue A, Benhayoun M, Lebrec D and Benhamou J: Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology. 100:520–528. 1991.
2.	Simonneau G, Galič N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R and Beghetti M: Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 43:S5–S12. 2004. View Article : Google Scholar
3.	Krowka MJ: Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology. 25:1282–1284. 1997. View Article : Google Scholar : PubMed/NCBI
4.	Castro M, Krowka MJ, Schroeder DR, Beck KC, Plevak DJ, Rettke SR, Cortese DA and Wiesner RH: Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clinic Proc. 71:543–551. 1996. View Article : Google Scholar : PubMed/NCBI
5.	Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S and Kaplowitz N: Clinical risk factors for portopulmonary hypertension. Hepatology. 48:196–203. 2008. View Article : Google Scholar : PubMed/NCBI
6.	Kalambokis GN, Mouzaki A, Rodi M, Pappas K, Korantzopoulos P and Tsianos EV: Circulating endotoxin and interleukin-6 levels are associated with Doppler-evaluated pulmonary vascular resistance in cirrhotic patients. Hepatol Int. 6:783–789. 2012. View Article : Google Scholar
7.	Shetty K, Rybicki L and Carey WD: The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology. 25:1049–1053. 1997. View Article : Google Scholar : PubMed/NCBI
8.	Cotton CL, Gandhi S, Vaitkus PT, Massad MG, Benedetti E, Mrtek RG and Wiley TE: Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. Liver Transpl. 8:1051–1054. 2002. View Article : Google Scholar : PubMed/NCBI
9.	Sciomer S, Magrì D and Badagliacca R: Non-invasive assessment of pulmonary hypertension: Doppler-echocardiography. Pulm Pharmacol Ther. 20:135–140. 2007. View Article : Google Scholar : PubMed/NCBI
10.	Krowka MJ: Evolving dilemmas and management of portopulmonary hypertension. Semin Liver Dis. 26:265–272. 2006. View Article : Google Scholar : PubMed/NCBI
11.	Golbin JM and Krowka MJ: Portopulmonary hypertension. Clin Chest Med. 28:203–218. 2007. View Article : Google Scholar
12.	Scapellato F, Temporelli PL, Eleuteri E, Corrà U, Imparato A and Giannuzzi P: Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic heart failure. J Am Coll Cardiol. 37:1813–1819. 2001. View Article : Google Scholar
13.	Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA and Lester SJ: A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol. 41:1021–1027. 2003. View Article : Google Scholar : PubMed/NCBI
14.	Farzaneh-Far R, McKeown BH, Dang D, Roberts J, Schiller NB and Foster E: Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation. Am J Cardiol. 101:259–262. 2008. View Article : Google Scholar : PubMed/NCBI
15.	Kim W, Krowka MJ, Plevak DJ, Lee J, Rettke SR, Frantz RP and Wiesner RH: Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl. 6:453–458. 2000. View Article : Google Scholar : PubMed/NCBI
16.	Chemla D, Castelain V, Humbert M, Hébert JL, Simonneau G, Lecarpentier Y and Hervé P: New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest. 126:1313–1317. 2004. View Article : Google Scholar : PubMed/NCBI
17.	Robalino BD and Moodie DS: Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol. 17:492–498. 1991. View Article : Google Scholar
18.	Benjaminov F, Prentice M, Sniderman K, Siu S, Liu P and Wong F: Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut. 52:1355–1362. 2003. View Article : Google Scholar : PubMed/NCBI
19.	Hoeper MM, Krowka MJ and Strassburg CP: Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 363:1461–1468. 2004. View Article : Google Scholar : PubMed/NCBI
20.	Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF and Chabot F: Pulmonary arterial hypertension in France. Am J Respir Crit Care Med. 173:1023–1030. 2006. View Article : Google Scholar : PubMed/NCBI
21.	Lai K, McFadzean A and Yeung R: Microembolic pulmonary hypertension in pyogenic cholangitis. Br Med J. 1:22–24. 1968. View Article : Google Scholar : PubMed/NCBI
22.	Groszmann RJ: Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology. 20:1359–1363. 1994.